FBN1 and metabolic dysfunction-associated steatotic liver disease: Conversely, these genes were not differentially expressed in the NAFLD dominant datasets (Supplementary File 1, Fig. S5), suggesting EFEMP1, FBN1 and THBS2 maybe the novel candidate biomarkers for fibrosing-NAFLD.